BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17541234)

  • 1. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
    Tokimatsu I; Kushima H; Iwata A; Hashinaga K; Umeki K; Ohama M; Kohno K; Ishii H; Kishi K; Ogata M; Hiramatsu K; Saikawa T; Kadota J
    Intern Med; 2007; 46(11):775-9. PubMed ID: 17541234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
    Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Ikeda F
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
    Warn PA; Morrissey G; Morrissey J; Denning DW
    J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful micafungin (FK463) treatment of invasive pulmonary aspergillosis in a patient with acute lymphoblastic leukemia in a phase II study.
    Ota S; Tanaka J; Kahata K; Toubai T; Kondo K; Mori A; Toyoshima N; Musashi M; Asaka M; Imamura M
    Int J Hematol; 2004 May; 79(4):390-3. PubMed ID: 15218972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antifungal activity and clinical efficacy of micafungin (funguard)].
    Ikeda F
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two cases of pulmonary aspergillosis successfully treated with combinated micafungin and itraconazole therapy].
    Furugen M; Haranaga S; Touyama M; Shiroma R; Yara S; Shinzato T; Higa F; Tateyama M; Saitou A; Fujita J
    Kansenshogaku Zasshi; 2005 Dec; 79(12):951-6. PubMed ID: 16444977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined effect of micafangin and itraconazole on severe aspergillosis of the bilateral pleural cavities in a patient with Wegener's granulomatosis].
    Endo H; Yoshida H; Kondo H; Kume H; Nomura T
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(1):25-9. PubMed ID: 16465137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sucessful treatment by micafungin of pulmonary aspergillosis occurring in an old lung abscess].
    Hirata A; Uji M; Matsushita H
    Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):221-4. PubMed ID: 15966368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
    Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
    Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Micafungin therapy for a case of chronic necrotizing pulmonary aspergillosis].
    Sugino Y; Fujii M; Kato M; Yagi A; Kawabata A
    Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):458-63. PubMed ID: 16841718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
    Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
    Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
    Clemons KV; Stevens DA
    Med Mycol; 2006 Feb; 44(1):69-73. PubMed ID: 16805095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice.
    Nakai T; Hatano K; Ikeda F; Shibuya K
    Med Mycol; 2005 Aug; 43(5):439-45. PubMed ID: 16178373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective blood concentration of micafungin for pulmonary aspergillosis.
    Shimoeda S; Ohta S; Kobayashi H; Yamato S; Sasaki M; Kawano K
    Biol Pharm Bull; 2006 Sep; 29(9):1886-91. PubMed ID: 16946503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guidelines for the management of deep mycosis in neutropenic patients].
    Yoshida M
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(4):209-15. PubMed ID: 15550917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
    Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR
    Clin Microbiol Infect; 2003 Dec; 9(12):1238-41. PubMed ID: 14686991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety.
    Wiederhold NP; Lewis JS
    Expert Opin Pharmacother; 2007 Jun; 8(8):1155-66. PubMed ID: 17516879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
    Goldberg SL; Geha DJ; Marshall WF; Inwards DJ; Hoagland HC
    Clin Infect Dis; 1993 Jun; 16(6):803-5. PubMed ID: 8392389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin: a therapeutic review.
    Higashiyama Y; Kohno S
    Expert Rev Anti Infect Ther; 2004 Jun; 2(3):345-55. PubMed ID: 15482200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.